Benefit-Finding Intervention Delivered Individually to Alzheimer Family Caregivers: Longer-Term Outcomes of a Randomized Double-Blind Controlled Trial
Contact Information
Keywords
Sheung-Tak Cheng, PhD, takcheng@eduhk.hk
Dementia caregiving, Depression, Cognitive reappraisal, Positive aspects of caregiving, Randomized controlled trial
Abstract
Objectives: To examine the longer-term effects of benefit-finding on caregivers' depressive symptoms (primary outcome), and global burden, role overload, psychological well-being, and positive aspects of caregiving (secondary outcomes). Method: Ninety-six Hong Kong Chinese caregivers of relatives with Alzheimer's disease were randomly assigned to receive the benefit-finding intervention (BFT) or one of the two control conditions, namely, simplified psychoeducation (lectures only; SIM-PE) or standard psychoeducation (STD-PE). Caregivers received four biweekly one-to-one interventions of 3 hours each at their own homes. We focused on outcomes measured at 4- and 10-month follow-ups. The trajectories of intervention effects were modeled by BFT × time and BFT × time2 interaction terms. Results: Mixed-effects regression showed significant BFT × time2 interaction effects on depressive symptoms against both control conditions, suggesting diminishing BFT effects over time. Z tests showed that, compared with controls, BFT participants reported substantial reductions in depressive symptoms at 4-month follow-up (d = -0.85 and -0.75 vs. SIM-PE and STD-PE, respectively). For depressive symptoms measured at 10-month follow-up, BFT was indistinguishable from STD-PE, whereas a moderate effect was observed in comparison with SIM-PE (d = -0.52). Moreover, positive aspects of caregiving, but not other secondary outcomes, continued to show intervention effect up to 10-month follow-up. Discussion: Benefit-finding is an efficacious intervention for depressive symptoms in Alzheimer caregivers, with strong effects in the medium-term post-intervention and possible moderate effects in the longer-term post-intervention.
Citation
Sheung-Tak Cheng, Emily P M Mak, Timothy Kwok, Helene Fung, Linda C W Lam, Benefit-Finding Intervention Delivered Individually to Alzheimer Family Caregivers: Longer-Term Outcomes of a Randomized Double-Blind Controlled Trial, The Journals of Gerontology: Series B, Volume 75, Issue 9, November 2020, Pages 1884–1893, https://doi.org/10.1093/geronb/gbz118
DOI
10.1093/geronb/gbz118
EWB Constructs:
(1) goal pursuit
(2) life satisfaction
(3) positive affect
(5) sense of meaning
EWB Measures:
(1) Psychological Well-being Scale Ryff’s (1989): Goal Pursuit, Life Satisfaction, Positive Affect, Sense of Meaning
data availability:
Yes
data availability details:
Data for the study can be obtained from the corresponding author.
brain imaging paradigm:
N/A
N/A
brain region/circuit:
Exclusion Criteria:
Exclude the Care-recipient having parkinsonism or other forms of dementia (e.g., mixed dementia).
Inclusion Criteria
(a) being a primary caregiver aged 18 years or over
(b) providing ≥14 hr of care per week to a relative with Alzheimer’s disease in the mild-to-moderate stage (per Clinical Dementia Rating; Morris, 1993)
(c) a Mini-Mental State Examination (Cantonese version) score not, suggesting that cognitive impairment
(d) at least mild depressive symptoms operationalized as a score of ≥3 on the Hamilton Depression Rating Scale
Non-EWB Behavioral
Measures:
(1) Depressive symptoms: Hamilton Depression Rating Scale
(2) Global Burden: Zairt Burden Interview
(3) role overload: Pearlin, Mullan, Semple, and Skaff’s (1990)
(4) behavioral and psychological symptoms of dementia: Neuropsychiatry Inventory (Cummings, 1997)
(5) Functional impairment: OARS Multidimensional Functional Assessment Questionnaire (Fillenbaum & Smyer, 1981)
First author:
Sheung-Tak Cheng
species:
Human
sample size:
96
study design:
(5) RCT
longitudinal data?
Yes
younger controls?
No
interventions:
Benefit-Finding Intervention
study population:
(1) cognitively healthy adults
sex (% female):
86%
ethnicity (%white)
0% (Hong Kong)
Age (mean, sd):
56.16, 10.56
biological/Physiological Measures:
N/A